THERE has been ample research across the globe on Covid-19 in the wake of the pandemic.
Pharmaceutical companies have been working on vaccines to combat the disease, but such vaccines may not be available for the public at large until next year.
In the meantime, the people are required to take measures such as wearing face masks, frequent sanitising, and social distancing to keep Covid-19 at bay.
Amidst such efforts, Japanese multinational electronics company Panasonic initiated collaboration with Paris-based global contract research organisation Texcell on its nanoe X technology that employs hydroxyl radicals to inhibit the novel coronavirus SARS-CoV-2 which causes Covid-19.